Vivos Inc (RDGL)
Vivos Inc. is a healthcare company listed on OTC Markets under the ticker RDGL. As a common stock issuer in the healthcare equipment and supplies segment, the company develops radiation oncology medical devices focused on brachytherapy and precision radionuclide therapy. Its work includes RadioGel, an yttrium-90 based injectable particle-gel under development for treating cancerous tumors in people and animals, as well as IsoPet, a product intended for solid tumor treatment in animals. Vivos is also advancing additional products and technologies under names including Alpha-Gel, Beta-Gel, Gamma-Gel, Precisiongel, a hydrogel, and a universal laboratory cooling device. The company, formerly known as Advanced Medical Isotope Corporation, adopted its current name in December 2017 and was incorporated in 1994. It is headquartered in Kennewick, Washington.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RDGL
|
$0.030
|
-35.8% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
229.9x
|
22.932 M
|
29.9 M
|
0.3%
|
95.5%
|
64.1
|
69.9%
|
